Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Terazosin And Metabolic Engagement in Alzheimer's Disease

NCT07796308 is registered in ClinicalTrials.gov with Qiang Zhang as lead sponsor.

NCT NCT07796308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07796308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Terazosin And Metabolic Engagement in Alzheimer's Disease
Lead sponsor
Qiang Zhang
Phase
Phase 2
Overall status
Not yet recruiting
Start date
August 1, 2027
Completion date
July 31, 2032
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer s disease